Stents in paediatric and adult congenital interventional cardiac catheterization

Arch Cardiovasc Dis. 2014 Aug-Sep;107(8-9):462-75. doi: 10.1016/j.acvd.2014.06.005. Epub 2014 Aug 12.

Abstract

A 'stent' is a tubular meshed endoprosthesis that has contributed to the development of interventional catheterization over the past 30 years. In congenital heart diseases, stents have offered new solutions to the treatment of congenital vessel stenosis or postsurgical lesions, to maintain or close shunt patency, and to allow transcatheter valve replacement. First, stents were made of bare metal. Then, stent frameworks evolved to achieve a better compromise between radial strength and flexibility. However, almost all stents used currently in children have not been approved for vascular lesions in children and are therefore used 'off-label'. Furthermore, the inability of stents to follow natural vessel growth still limits their use in low-weight children and infants. Recently, bioresorbable stents have been manufactured and may overcome this issue; they are made from materials that may dissolve or be absorbed in the body. In this review, we aim to describe the history of stent development, the technical characteristics of stents used currently, the clinical applications and results, and the latest technological developments and perspectives in paediatric and adult congenital cardiac catheterization.

Keywords: Bioresorbable stent; Cardiologie congénitale; Cardiologie interventionnelle; Cardiologie pédiatrique; Congenital heart diseases; Interventional cardiology; Paediatric cardiology; Stent; Stent biorésorbable.

Publication types

  • Review
  • Video-Audio Media

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / instrumentation*
  • Cardiac Catheterization / adverse effects
  • Cardiac Catheterization / instrumentation*
  • Child
  • Child, Preschool
  • Female
  • Heart Defects, Congenital / diagnosis
  • Heart Defects, Congenital / therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prosthesis Design
  • Risk Factors
  • Stents*
  • Treatment Outcome